• 1
    Dulac O, Plouin P. Infantile spasms and West syndrome. In: WyllieE, ed. The treatment of epilepsy: principles and practice. Philadelphia : Lea & Febiger, 1993:46491.
  • 2
    Dulac O, Schlumberger E. Treatment of West syndrome. In: WylieE, ed. The treatment of epilepsy: principles and practice. Philadelphia : Lea & Febiger, 1993:595603.
  • 3
    Dulac O, Plouin P, Schlumberger E. Infantile spasms. In: WyllieE, ed. The treatment of epilepsy: principles and practice. Baltimore : Williams & Wilkins, 1996:54072.
  • 4
    Dulac O. Infantile spasms and West syndrome. London : WB Saunders, 1994.
  • 5
    Chugani HT, Conti JR. Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography. J Child Neurol 1996;11:448.
  • 6
    Hosain S, Nagarajan L, Carson D, Solomon G, Mast J, Labar D. Felbamate for refractory infantile spasms. J Child Neurol 1997;12:4668.
  • 7
    Hurst DL, Rolan TD. The use of felbamate to treat infantile spasms. J Child Neurol 1995;10:1346.
  • 8
    Stafström CE. The use of felbamate to treat infantile spasms. J Child Neurol 1996;11:1701.
  • 9
    Mareš P, Velíšek L. N-Methyl-D-aspartate (NMDA)-induced seizures in developing rats. Dev Brain Res 1992;65:1859.
  • 10
    Schoepp DD, Gamble AY, Salhoff CR, Johnson BG, Ornstein PL. Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes. Eur J Pharmacol 1990;182:4217.
  • 11
    Velíšek L, Mareš P. Age-dependent anticonvulsant action of clonazepam in the N-methyl-D-aspartate model of seizures. Pharmacol Biochem Behav 1995;52:2916.
  • 12
    Gottlieb A, Keydar I, Epstain HT. Rodent brain growth stages: an analytical review. Biol Neonate 1977;32:16676.
  • 13
    Donaldson HH. A comparison of the albino rat with man in respect to the growth of the brain and of the spinal cord. J Comp Neurol Psychol 1908;18:34589.
  • 14
    Eayrs JT, Goodhead B. Postnatal development of the cerebral cortex in the rat. J Anat 1959;92:385402.
  • 15
    Petit TL, LeBoutillier JC, Brooks WJ. Altered sensitivity to NMDA following developmental lead exposure in rats. Physiol Behav 1992;52:68793.
  • 16
    Miller RD, Monsul NT, Vender JR, Lehmann JC. NMDA- and endothelin-1-induced increases in blood-brain barrier permeability quantitated with Lucifer yellow. J Neurol Sci 1996;136:3740.
  • 17
    Brace H, Latimer M, Winn P. Neurotoxicity, blood-brain barrier breakdown, demyelination and remyelination associated with NMDA-induced lesions of the rat lateral hypothalamus. Brain Res Bull 1997;43:44755.
  • 18
    Chi OZ, Chang Q, Weiss HR. Effects of topical N-methyl-D-aspartate on blood-brain barrier permeability in the cerebral cortex of normotensive and hypertensive rats. Neurol Res 1997;19:53944.
  • 19
    Dietrich WD, Alonso O, Halley M, Busto R, Globus MY. Intraventricular infusion of N-methyl-D-aspartate. 1. Acute blood-brain barrier consequences. Acta Neuropathol 1992;84:6219.
  • 20
    Schlumberger E, Dulac O. A simple, effective and well-tolerated treatment regimen for West syndrome. Dev Med Child Neurol 1994;36:86372.
  • 21
    Prats JM, Garaizar C, Rua MJ, Garcia-Nieto ML, Madoz P. Infantile spasms treated with high doses of sodium valproate: initial response and follow-up. Dev Med Child Neurol 1991;33:61725.
  • 22
    Blennow G, Starck L. High dose B6 treatment in infantile spasms. Neuropediatrics 1986;17:710.
  • 23
    Ohtsuka Y, Matsuda M, Ogino T, Kobayashi K, Ohtahara S. Treatment of the West syndrome with high-dose pyridoxal phosphate. Brain Dev 1987;9:41821.
  • 24
    Mikolášová R, Velíšek L, Vorlíček J, Mareš P. Developmental changes of ketamine action against epileptic afterdischarges induced by hippocampal stimulation in rats. Brain Res 1994;81:10512.
  • 25
    Pinheiro Carrera M, Brunhara FC, Schwarting RK, Tomaz C. Drug conditioning induced by intrastriatal apomorphine administration. Brain Res 1998;790:606.
  • 26
    Fariello RG, McArthur RA, Bonsignori A, et al. Preclinical evaluation of PNU-151774E as a novel anticonvulsant. J Pharmacol Exp Ther 1998;285:397403.
  • 27
    Murphy MP, Rick JT, Milgram NW, Ivy GO. A simple and rapid test of sensorimotor function in the aged rat. Neurobiol Learn Mem 1995;64:1816.
  • 28
    Hliňák Z, Krejčí I. Concurrent administration of subeffective doses of scopolamine and MK-801 produces a short-term amnesia for the elevated plus-maze in mice. Behav Brain Res 1998;91:839.
  • 29
    Onodera K, Miyazaki S, Imaizumi M, Stark H, Schunack W. Improvement by FUB 181, a novel histamine H3-receptor antagonist, of learning and memory in the elevated plus-maze test in mice. Naunyn Schmiedebergs Arch Pharmacol 1998;357:50813.
  • 30
    Podhorná J, Franklin KB. Lesions of the pedunclopontine tegmental nucleus increase anxiety in rats. Neuroreport 1998;9:17836.
  • 31
    Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York : Academic Press, 1988.
  • 32
    Stafström CE, Tandon P, Hori A, Liu Z, Mikati MA, Holmes GL. Acute effects of MK801 on kainic acid-induced seizures in neonatal rats. Epilepsy Res 1997;26:33544.
  • 33
    Verešová S, Kábová R, Velíšek L. Proconvulsant effects induced by pyridoxine in young rats. Epilepsy Res 1998;29:25964.
  • 34
    Riikonen R. Current knowledge of actions of ACTH and corticosteroids. Brain Dev 1987;9:40914.
  • 35
    Snead OC. Adrenocorticotropic hormone (ACTH). In: WyllieE, ed. The treatment of epilepsy: principles and practice. Baltimore : Williams & Wilkins, 1996:9316.
  • 36
    Baram TZ, Mitchell WG, Snead OC, Horton EJ, Saito M. Brainadrenal axis hormones are altered in the CSF of infants with massive infantile spasms. Neurology 1992;42:11715.
  • 37
    Holmes GL. Effect of non-sex hormones on neuronal excitability, seizures, and the electroencephalogram. Epilepsia 1991;32:S118.
  • 38
    Kanayama M, Ishikawa T, Tauchi A, Kobayashi M, Takasaka Y, Shibata H. ACTH-induced seizures in an infant with West syndrome. Brain Dev 1989;11:32931.
  • 39
    Baram TZ, Schultz L. ACTH does not control neonatal seizures induced by administration of exogenous corticotropin-releasing hormone. Epilepsia 1995;36:1748.
  • 40
    Conforti N, Feldman S. Effect of cortisol on the excitability of limbic structures of the brain in freely moving rats. J Neurol Sci 1975;26:2938.
  • 41
    Talmi M, Carlier E, Bengelloun W, Soumireu-Mourat B. Synergistic action of corticosterone on kainic acid-induced electrophysiological alterations in the hippocampus. Brain Res 1995;704:97102.
  • 42
    Lee PHK, Grimes L, Hong JS. Glucocorticoids potentiate kainic acid-induced seizures and wet dog shakes. Brain Res 1989;480:3225.
  • 43
    Sapolsky R, Krey L, McEwen B. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985;5:12227.
  • 44
    Czuczwar S, Frey H, Löscher W. Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antipileptic drugs and other agents. Eur J Pharmacol 1984;108:27380.
  • 45
    Siemes H, Spohr HL, Michael T, Nau H. Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia 1988;29:55360.
  • 46
    Ohtsuka Y, Amano R, Mizukawa M, Oka E, Ohtahara S. Treatment of intractable childhood epilepsy with high-dose valproate. Epilepsia 1992;33:15864.
  • 47
    Bayley M, Walsh FM, Valaske MJ. Fatal overdose from Bendectin. Clin Pediatr 1975;14:5079, 514.
  • 48
    Ebadi M, Metzler DE, Christenson WR. Convulsant activity of pyridoxal sulphate and phosphonoethyl pyridoxal: antagonism by GABA and its synthetic analogues. Neuropharmacology 1983;22:86573.
  • 49
    Weigand C, Eckler C, Chen K. Action and toxicity of vitamin B6 hydrochloride. Proc Soc Exp Biol Med 1940;44:14751.
  • 50
    Ishioka N, Sato J, Nakamura J, Ohkubo T, Takeda A, Kurioka S. In vivo modification of GABAA receptor with a high dose of pyridoxal phosphate induces tonic-clonic convulsion in immature mice. Neurochem Int 1995;26:36973.
  • 51
    Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 1995;11:4551.
  • 52
    Gibbs F, Gibbs E. Atlas of electroencephalography: epilepsy. Cambridge : Addison-Wesley, 1952.
  • 53
    Hrachovy RA, Frost JD, Kellaway P. Hypsarrhythmia: variations on the theme. Epilepsia 1984;25:31725.
  • 54
    Jeavons PM, Harper JR, Bower BD. Long-term prognosis in infantile spasms: a follow-up report on 112 cases. Dev Med Child Neurol 1970;12:41321.
  • 55
    Kellaway P, Hrachovy RA, Frost JD Jr, Zion T. Precise characterization and quantification of infantile spasms. Ann Neurol 1979;6:2148.
  • 56
    Aicardi J. Myoclonic epilepsies of infancy and childhood. Adv Neurol 1986;43:1131.
  • 57
    Plouin P, Dulac O, Jalin C, Chiron C. Twenty-four-hour ambulatory EEG monitoring in infantile spasms. Epilepsia 1993;34:68691.
  • 58
    Fusco L, Vigevano F. Ictal clinical electroencephalographic findings of spasms in West syndrome. Epilepsia 1993;34:6718.
  • 59
    McDonald JW, Silverstein FS, Johnston MV. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 1988;459:2003.
  • 60
    McDonald JW, Silverstein FS, Johnston MV. Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model. Brain Res 1989;490:3340.
  • 61
    Sperber EF. The relationship between seizures and damage in the maturing brain. In: HeinemannU, EngelJJr, AvanziniG, MeldrumBS, Mouritzen-DamA, WasterlainC, eds. Progressive nature of epileptogenesis. Amsterdam : Elsevier, 1996;365:76.
  • 62
    Mareš P, Folbergrová J, Langmeier M, Haugvicová R, Kubová H. Convulsant action of D,L-homocysteic acid and its stereoisomers in immature rats. Epilepsia 1997;38:76776.